Journal article icon

Journal article

Targeted therapies: Manufacturer sponsorship bias in economic analyses matters

Abstract:
A qualitative study indicates that there is a positive selection bias towards favourable economic analysis of targeted therapies, when these are funded by the manufacturer. At a time of increasing budgetary constraints and public scrutiny of the relationship between industry and the professions, we need a more mixed economy of funding for this field. © 2012 Macmillan Publishers Limited. All rights reserved.

Actions


Access Document


Publisher copy:
10.1038/nrclinonc.2012.75

Authors


Elzawawy, A More by this author
Journal:
Nature Reviews Clinical Oncology
Volume:
9
Issue:
6
Pages:
309-310
Publication date:
2012-06-05
DOI:
EISSN:
1759-4782
ISSN:
1759-4774
URN:
uuid:c4a2077d-c415-4ffd-a9e0-d794300844a7
Source identifiers:
340381
Local pid:
pubs:340381
Language:
English

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP